<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02496806</url>
  </required_header>
  <id_info>
    <org_study_id>SWAFAX11/18</org_study_id>
    <nct_id>NCT02496806</nct_id>
  </id_info>
  <brief_title>The Absorption and Metabolism of Seaweed Polyphenols in Humans</brief_title>
  <acronym>SWAFAX</acronym>
  <official_title>Seaweed Derived Anti-inflammatory Agents and Antioxidants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ulster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brown seaweeds are a rich source of phlorotannins, a characteristic class of polyphenols&#xD;
      which are unique to seaweeds of this type and can comprise 5 to 15 % of the dried weight.&#xD;
      Unlike other classes of polyphenols, there is a lack of knowledge regarding phlorotannins and&#xD;
      their bioavailability and bioactivity. The purpose of this study is to investigate the&#xD;
      absorption and metabolism of seaweed polyphenols in humans. As part of an EC project&#xD;
      (SWAFAX), an acute clinical intervention will be conducted to investigate the metabolism/&#xD;
      bioavailability of brown seaweed phlorotannins. Urine and plasma samples from 24 healthy&#xD;
      volunteers that consumed a seaweed capsule containing polyphenols will be collected before&#xD;
      and after the intervention. Data emanating from this project will provide strong scientific&#xD;
      evidence for bioavailability and health promoting activity of a seaweed polyphenol extract in&#xD;
      human volunteers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Seaweed polyphenol metabolites in urine</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Seaweed polyphenol metabolites in plasma</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Citokine levels in plasma</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400mg capsule containing seaweed extract (treatment) Intervention: Dietary Supplement: Treatment capsule containing seaweed extract (treatment)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Seaweed extract</intervention_name>
    <description>Treatment capsule containing seaweed extract (treatment)</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Good general health&#xD;
&#xD;
          -  Body Mass Index of 18-30 Kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to swallow capsules&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Alcohol intake of &gt;21 units/wk&#xD;
&#xD;
          -  Blood pressure &gt; 150/90 mmHg&#xD;
&#xD;
          -  Any dietary restrictions or weight reducing diet&#xD;
&#xD;
          -  Vegetarian&#xD;
&#xD;
          -  Heamoglobin levels&lt; 125 g/l for male, &lt; 110 g/l for female,&#xD;
&#xD;
          -  Gamma GT levels &gt; 80 IU/l&#xD;
&#xD;
          -  Cholesterol levels &gt; 6.5 mmol/l&#xD;
&#xD;
          -  Myocardial infarction or stroke in the previous 12 months&#xD;
&#xD;
          -  Gastrointestinal disease or chronic gastrointestinal disorders&#xD;
&#xD;
          -  Reproductive disorder&#xD;
&#xD;
          -  Blood-clotting disorder&#xD;
&#xD;
          -  Metabolic disorders&#xD;
&#xD;
          -  Lipid-modifying medication&#xD;
&#xD;
          -  Blood clotting mdication&#xD;
&#xD;
          -  Antibiotic medication in previous 3 months before study&#xD;
&#xD;
          -  Lactation&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Females of childbearing potential and not using effective contraceptive precautions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>June 24, 2015</study_first_submitted>
  <study_first_submitted_qc>July 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2015</study_first_posted>
  <last_update_submitted>July 9, 2015</last_update_submitted>
  <last_update_submitted_qc>July 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Reading</investigator_affiliation>
    <investigator_full_name>DR GIULIA CORONA</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Polyphenols</keyword>
  <keyword>Absorption</keyword>
  <keyword>Metabolism</keyword>
  <keyword>Phlorotannins</keyword>
  <keyword>Seaweeds</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

